全文获取类型
收费全文 | 354篇 |
免费 | 32篇 |
专业分类
386篇 |
出版年
2023年 | 1篇 |
2022年 | 10篇 |
2021年 | 20篇 |
2020年 | 13篇 |
2019年 | 4篇 |
2018年 | 6篇 |
2017年 | 13篇 |
2016年 | 15篇 |
2015年 | 22篇 |
2014年 | 25篇 |
2013年 | 31篇 |
2012年 | 24篇 |
2011年 | 37篇 |
2010年 | 19篇 |
2009年 | 16篇 |
2008年 | 15篇 |
2007年 | 11篇 |
2006年 | 9篇 |
2005年 | 12篇 |
2004年 | 12篇 |
2003年 | 4篇 |
2002年 | 13篇 |
2001年 | 3篇 |
2000年 | 5篇 |
1999年 | 8篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 3篇 |
1972年 | 1篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有386条查询结果,搜索用时 15 毫秒
121.
Individuals with chronic HCV infection have impaired response to vaccine, though the etiology remains to be elucidated. Dendritic cells (DC) and monocytes (MN) provide antigen uptake, processing, presentation, and costimulatory functions necessary to achieve optimal immune responses. The integrity of antigen processing and presentation function within these antigen presenting cells (APC) in the setting of HCV infection has been unclear. We used a novel T cell hybridoma system that specifically measures MHC-II antigen processing and presentation function of human APC. Results demonstrate MHC-II antigen processing and presentation function is preserved in both myeloid DC (mDC) and MN in the peripheral blood of chronically HCV-infected individuals, and indicates that an alteration in this function does not likely underlie the defective HCV-infected host response to vaccination. 相似文献
122.
Machteld E. Boel Marcus J. Rijken Tjalling Leenstra Aung Pyae Phyo Mupawjay Pimanpanarak Naw Lily Keereecharoen Stephane Proux Natthapon Laochan Mallika Imwong Pratap Singhasivanon Nicholas J. White Rose McGready Fran?ois H. Nosten 《PloS one》2013,8(3)
Background
Several studies have shown a prolonged or increased susceptibility to malaria in the post-partum period. A matched cohort study was conducted to evaluate prospectively the susceptibility to malaria of post-partum women in an area where P.falciparum and P.vivax are prevalent.Methods
In an area of low seasonal malaria transmission on the Thai-Myanmar border pregnant women attending antenatal clinics were matched to a non-pregnant, non-post-partum control and followed up prospectively until 12 weeks after delivery.Results
Post-partum women (n = 744) experienced significantly less P.falciparum episodes than controls (hazard ratio (HR) 0.39 (95%CI 0.21–0.72) p = 0.003) but significantly more P.vivax (HR 1.34 (1.05–1.72) p = 0.018). The reduced risk of falciparum malaria was accounted for by reduced exposure, whereas a history of P.vivax infection during pregnancy was a strong risk factor for P.vivax in post-partum women (HR 13.98 (9.13–21.41), p<0.001). After controlling for effect modification by history of P.vivax, post-partum women were not more susceptible to P.vivax than controls (HR: 0.33 (0.21–0.51), p<0.001). Genotyping of pre-and post-partum infections (n⊕ = ⊕10) showed that each post-partum P.falciparum was a newly acquired infection.Conclusions
In this area of low seasonal malaria transmission post-partum women were less likely to develop falciparum malaria but more likely to develop vivax malaria than controls. This was explained by reduced risk of exposure and increased risk of relapse, respectively. There was no evidence for altered susceptibility to malaria in the post-partum period. The treatment of vivax malaria during and immediately after pregnancy needs to be improved. 相似文献123.
Background
This systematic review and meta-analysis of prospective studies evaluates the association between adiponectin concentrations and risk of cardiovascular disease (CVD) in individuals with diabetes mellitus (DM).Methods
PubMed and Embase were searched for prospective studies on the association of adiponectin concentrations and risk of CVD up to June 2013. Random-effect model was selected to pool the relative risk (RR) and 95% CI.Results
Five prospective cohort studies and one nested case-control studies met the included criterion. The estimated summary RR and 95% CI of five prospective cohort studies for type 2 diabetes comparing top vs low tertile of adiponectin concentrations was 0.99 (95% CI: 0.67–1.45), with significant heterogeneity between studies (p = 0.037, I 2 = 60.9%). This heterogeneity was explained by one study conducted in Korean.Conclusions
This study represents the first meta-analysis between adiponectin levels and CVD in diabetic patients and indicated no association was found. This result should be verified further by large sample size, long duration of follow-up, and well-designed prospective clinical trials. 相似文献124.
Christophe Rosty Joanne P. Young Michael D. Walsh Mark Clendenning Kristy Sanderson Rhiannon J. Walters Susan Parry Mark A. Jenkins Aung Ko Win Melissa C. Southey John L. Hopper Graham G. Giles Elizabeth J. Williamson Dallas R. English Daniel D. Buchanan 《PloS one》2013,8(6)
Mutations in PIK3CA are present in 10 to 15% of colorectal carcinomas. We aimed to examine how PIK3CA mutations relate to other molecular alterations in colorectal carcinoma, to pathologic phenotype and survival. PIK3CA mutation testing was carried out using direct sequencing on 757 incident tumors from the Melbourne Collaborative Cohort Study. The status of O-6-methylguanine-DNA methyltransferase (MGMT) was assessed using both immunohistochemistry and methyLight techniques. Microsatellite instability, CpG island phenotype (CIMP), KRAS and BRAF V600E mutation status, and pathology review features were derived from previous reports. PIK3CA mutation was observed in 105 of 757 (14%) of carcinomas, characterized by location in the proximal colon (54% vs. 34%; P<0.001) and an increased frequency of KRAS mutation (48% vs. 25%; P<0.001). High-levels of CIMP were more frequently found in PIK3CA-mutated tumors compared with PIK3CA wild-type tumors (22% vs. 11%; P = 0.004). There was no difference in the prevalence of BRAF V600E mutation between these two tumor groups. PIK3CA-mutated tumors were associated with loss of MGMT expression (35% vs. 20%; P = 0.001) and the presence of tumor mucinous differentiation (54% vs. 32%; P<0.001). In patients with wild-type BRAF tumors, PIK3CA mutation was associated with poor survival (HR 1.51 95% CI 1.04–2.19, P = 0.03). In summary, PIK3CA-mutated colorectal carcinomas are more likely to develop in the proximal colon, to demonstrate high levels of CIMP, KRAS mutation and loss of MGMT expression. PIK3CA mutation also contributes to significantly decreased survival for patients with wild-type BRAF tumors. 相似文献
125.
Cho Naing Vanessa Racloz Maxine Anne Whittaker Kyan Aung Simon Andrew Reid Joon Wah Mak Marcel Tanner 《PloS one》2013,8(12)
Background
This study aimed to synthesize available evidence on the efficacy of dihydroartemisinin-piperaquine (DHP) in treating uncomplicated Plasmodium vivax malaria in people living in endemic countries.Methodology and Principal Findings
This is a meta-analysis of randomized controlled trials (RCT). We searched relevant studies in electronic databases up to May 2013. RCTs comparing efficacy of (DHP) with other artemisinin-based combination therapy (ACT), non-ACT or placebo were selected. The primary endpoint was efficacy expressed as PCR-corrected parasitological failure. Efficacy was pooled by hazard ratio (HR) and 95% CI, if studies reported time-to-event outcomes by the Kaplan-Meier method or data available for calculation of HR Nine RCTs with 14 datasets were included in the quantitative analysis. Overall, most of the studies were of high quality. Only a few studies compared with the same antimalarial drugs and reported the outcomes of the same follow-up duration, which created some difficulties in pooling of outcome data. We found the superiority of DHP over chloroquine (CQ) (at day > 42-63, HR:2.33, 95% CI:1.86-2.93, I 2: 0%) or artemether-lumefentrine (AL) (at day 42, HR:2.07, 95% CI:1.38-3.09, I 2: 39%). On the basis of GRADE criteria, further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.Discussion/Conclusion
Findings document that DHP is more efficacious than CQ and AL in treating uncomplicated P. vivax malaria. The better safety profile of DHP and the once-daily dosage improves adherence, and its fixed co-formulation ensures that both drugs (dihydroartemisinin and piperaquine) are taken together. However, DHP is not active against the hypnozoite stage of P. vivax. DHP has the potential to become an alternative antimalarial drug for the treatment uncomplicated P. vivax malaria. This should be substantiated by future RCTs with other ACTs. Additional work is required to establish how best to combine this treatment with appropriate antirelapse therapy (primaquine or other drugs under development). 相似文献126.
Robyn H. Guymer Paul N. Baird Mary Varsamidis Lucy Busija Peter N. Dimitrov Khin Zaw Aung Galina A. Makeyeva Andrea J. Richardson Lyndell Lim Liubov D. Robman 《PloS one》2013,8(12)
Background
HMG Co-A reductase inhibitors are ubiquitous in our community yet their potential role in age-related macular degeneration (AMD) remains to be determined.Methodology/Principal Findings
Objectives: To evaluate the effect of simvastatin on AMD progression and the effect modification by polymorphism in apolipoprotein E (ApoE) and complement factor H (CFH) genes. Design: A proof of concept double-masked randomized controlled study. Participants: 114 participants aged 53 to 91 years, with either bilateral intermediate AMD or unilateral non-advanced AMD (with advanced AMD in fellow eye), BCVA≥20/60 in at least one eye, and a normal lipid profile. Intervention: Simvastatin 40 mg/day or placebo, allocated 1∶1. Main outcome measures: Progression of AMD either to advanced AMD or in severity of non-advanced AMD. Results. The cumulative AMD progression rates were 70% in the placebo and 54% in the simvastatin group. Intent to treat multivariable logistic regression analysis, adjusted for age, sex, smoking and baseline AMD severity, showed a significant 2-fold decrease in the risk of progression in the simvastatin group: OR 0.43 (0.18–0.99), p = 0.047. Post-hoc analysis stratified by baseline AMD severity showed no benefit from treatment in those who had advanced AMD in the fellow eye before enrolment: OR 0.97 (0.27–3.52), p = 0.96, after adjusting for age, sex and smoking. However, there was a significant reduction in the risk of progression in the bilateral intermediate AMD group compared to placebo [adjusted OR 0.23 (0.07–0.75), p = 0.015]. The most prominent effect was observed amongst those who had the CC (Y402H) at risk genotype of the CFH gene [OR 0.08 (0.02–0.45), p = 0.004]. No evidence of harm from simvastatin intervention was detected.Conclusion/Significance
Simvastatin may slow progression of non-advanced AMD, especially for those with the at risk CFH genotype CC (Y402H). Further exploration of the potential use of statins for AMD, with emphasis on genetic subgroups, is warranted.Trial Registration
Australian New Zealand Clinical Trial Registry (ANZCTR) ACTRN1260500032065 相似文献127.
Gupta Anjali Bansal Gaultier Nicolas E. Aung Ngu War Purbojati Rikky W. Oliveira Elaine L. Wong Anthony Panicker Deepa Putra Alexander Uchida Akira Drautz-Moses Daniela I. Schuster Stephan C. 《Mycopathologia》2020,185(3):591-594
Mycopathologia - Penicillium oxalicum strain SGAir0226 was isolated from a tropical air sample collected in Singapore. The complete genome was assembled from long reads obtained from... 相似文献
128.
James A. Watson Thomas Lamb Jane Holmes David A. Warrell Khin Thida Thwin Zaw Lynn Aung Min Zaw Oo Myat Thet Nwe Frank Smithuis Elizabeth A. Ashley 《PLoS neglected tropical diseases》2020,14(11)
For most antivenoms there is little information from clinical studies to infer the relationship between dose and efficacy or dose and toxicity. Antivenom dose-finding studies usually recruit too few patients (e.g. fewer than 20) relative to clinically significant event rates (e.g. 5%). Model based adaptive dose-finding studies make efficient use of accrued patient data by using information across dosing levels, and converge rapidly to the contextually defined ‘optimal dose’. Adequate sample sizes for adaptive dose-finding trials can be determined by simulation. We propose a model based, Bayesian phase 2 type, adaptive clinical trial design for the characterisation of optimal initial antivenom doses in contexts where both efficacy and toxicity are measured as binary endpoints. This design is illustrated in the context of dose-finding for Daboia siamensis (Eastern Russell’s viper) envenoming in Myanmar. The design formalises the optimal initial dose of antivenom as the dose closest to that giving a pre-specified desired efficacy, but resulting in less than a pre-specified maximum toxicity. For Daboia siamensis envenoming, efficacy is defined as the restoration of blood coagulability within six hours, and toxicity is defined as anaphylaxis. Comprehensive simulation studies compared the expected behaviour of the model based design to a simpler rule based design (a modified ‘3+3’ design). The model based design can identify an optimal dose after fewer patients relative to the rule based design. Open source code for the simulations is made available in order to determine adequate sample sizes for future adaptive snakebite trials. Antivenom dose-finding trials would benefit from using standard model based adaptive designs. Dose-finding trials where rare events (e.g. 5% occurrence) are of clinical importance necessitate larger sample sizes than current practice. We will apply the model based design to determine a safe and efficacious dose for a novel lyophilised antivenom to treat Daboia siamensis envenoming in Myanmar. 相似文献
129.
Myint Omar Tsujimoto Hajime Ohnishi Nobuhiro Takeyama Tomohiro Kohda Masanori 《Journal of Ethology》2011,29(1):153-159
Theory predicts that individuals should adopt counterstrategies against intersexual conflict with their mating partners if
the counterstrategies are effective and cost-efficient. In fishes, males with parental care often cannibalize their own offspring,
which reduces the female’s fitness and creates intersexual conflicts. Males of the goby Rhinogobius flumineus cannibalize more eggs in the nest when they have access to additional females prior to spawning. Thus, it is predicted that
females will strategically avoid spawning with males that have high mate availability. In the present study, we experimentally
tested this prediction. When sexual pairs were placed in tanks, most females (control females; 21/22) successfully spawned
inside the nest. In contrast, when a gravid female (stimulus female) that was housed in a small transparent cage was shown
to the experiment pairs prior to spawning, only about half of the females (experiment females; 16/29) spawned inside the nest;
the remaining females released unfertilized eggs outside of the nest. Moreover, experiment females infrequently accepted and
followed males into nests, and delayed spawning more often than control females. R. flumineus females prefer males that court frequently. Indeed, experiment females that infrequently received courtship tended to spawn
outside of the nest. However, infrequent courtship alone could not explain outside-nest spawning, delay in spawning, or the
shorter stay of females in nests. These results imply that the presence of a stimulus female dampens female spawning with
males. We suggest that R. flumineus females may strategically reject or hesitate to spawn with males that have high mate availability, and that this spawning
avoidance may be a counterstrategy against male filial cannibalism. 相似文献
130.
Toe Toe Aung Maung Maung Than Ono Katsuhiro Mochida Yukira 《Wetlands Ecology and Management》2011,19(2):195-208
This paper assesses the extent of success and failure of mangrove plantations in Myanmar, restored by local people with the
help of foresters under a community forestry program initiated in 1995. The species of these restored plantations are Avicennia officinalis, Avicennia marina and Heritiera fomes, each of which was restored on two plots, one on low and one on high ground, yielding a total of six plots. These plots have
been continuously monitored in order to investigate survival and growth rates. The plots were established on abandoned land
that had been previously used for paddy cultivation. Cyclone Nargis hit these plantations during the monitoring period, at
the beginning of May, 2008. As a consequence, the survival rates of A. officinalis on low ground and A. marina on high ground declined slightly, but the overall affect was not severe. Excluding individuals affected by the cyclone, height
and diameter growth of A. officinalis and A. marina were significantly higher on low ground than on high ground, i.e. on sites thought to be consistently similar to the natural
habitats of these species. Contrary to these two Avicennia species, the height growth of H. fomes was higher on high ground than on low ground; the diameter growth was not significantly different. As the growth of H. fomes was very slow, however, it is still not possible to describe the differences clearly. This study may provide useful guidelines
for foresters and local people to establish successful mangrove restorations and to predict production from community-owned
mangrove forests. 相似文献